Evolution of the Epidemiological and Clinical Profile of Acute Chagas Disease in Brazil: A Decade-Long Study

Authors

  • Andressa Bianca Reis Lima UNIVERSIDADE FEDERAL DO MARANHÃO
  • Clara Vitoria Cavalcante Carvalho Universidade Federal do Maranhão
  • Vithória Emanuelle Souto Vieira CENTRO UNIVERSITÁRIO UNA
  • Erika da Silva Cavalcante INSTITUTO DE ENSINO SUPERIOR MÚLTIPLO – IESM
  • Ana Letícia de Souza e Souza CEUMA
  • Erik Rogai de Souza UNESC - CENTRO UNIVERSITÁRIO DO ESPÍRITO SANTO
  • Alex de Souza Borges UNIVERSIDADE REGIONAL DO CARIRI - URCA
  • Estefane Cavalcante Vasconcelos INSTITUTO TOCANTINENSE PRESIDENTE ANTÔNIO CARLOS (ITPAC)
  • Fernanda Prates Costa INSTITUTO TOCANTINENSE PRESIDENTE ANTÔNIO CARLOS (ITPAC)
  • Fernanda Bett UNIVERSIDAD NACIONAL DE ROSARIO
  • José Takamori Verri FUNEPE Janival
  • Lílian Ruth Ferreira Queiroz UNIVERSIDADE FEDERAL DA PARAÍBA – UFPB
  • Pâmella de Oliveira Carlos CENTRO UNIVERSITÁRIO CHRISTUS - UNICHRISTUS
  • Brenda Carrion Tomas CENTRO UNIVERSITÁRIO DO PLANALTO CENTRAL APPARECIDO DOS SANTOS
  • Ruth Gorete dos Santos Carvalho UNIVERSIDADE ESTADUAL DO PIAUÍ – UESPI
  • Andre Paschoa FACULDADE SOUZA MARQUES
  • Leticia Baldin Caltran UNIVERSIDADE NOVE DE JULHO
  • Luana Amorim Guilhon UNINOVAFAPI

DOI:

https://doi.org/10.36557/2674-8169.2024v6n8p1447-1458

Keywords:

Doença de chagas; Protozoário; Epidemiologia.

Abstract

Chagas disease is caused by the protozoan Trypanosoma cruzi, which infects species of triatomines. The acute phase of Chagas disease is associated with many symptoms that can range from mild to severe, making clinical diagnosis challenging due to the similarity with other infectious diseases. This is a descriptive, retrospective and quantitative study based on secondary data obtained from the Department of Information Technology of the Unified Health System (DATASUS), the Notification and Injuries System (SINAN) and the Hospital Morbidity System (SIH). The variables analyzed were: year of notification, region of residence, age group, color/race, sex, probable mode of infection, confirmation criteria and evolution. The total number of cases between 2012 and 2022 was 3,212. The North Region was the region with the highest number of confirmed cases of Chagas disease, corresponding to 95.29% (n = 3,061). Regarding age group, there was a higher frequency in adults aged between 20 and 39 years, equivalent to 34.15% (n=1,097). Males were the most frequently diagnosed with acute Chagas disease (53.76%). Regarding race/ethnicity, there was a higher frequency of brown individuals (80.32%). The most commonly used diagnostic criterion was laboratory testing, corresponding to 94.73% (n=3,043). The majority of the sample showed probable oral transmission, equivalent to 81.63% (n=2,622). Therefore, carrying out additional investigations on the prevalence of acute Chagas disease in the Brazilian population is crucial for the development of public policies aimed at preventing and controlling the disease.

Downloads

Download data is not yet available.

References

Bern et al. (2019): BERN, C.; MASTROROSSI, A.; NAGAMATSU, A. T.; FERRANTE, D.; LOPES, M. A.; VILASBOAS, F.; RIBEIRO, J.; SILVEIRA, R.; MENDES, A. L.; HUNGRIA, S. Progression of Chagas cardiomyopathy: Epidemiology and impact. Clinical Cardiology, v. 42, n. 10, p. 796-802, 2019. DOI: 10.1002/clc.23243.

Pinto et al. (2018): PINTO, A. Y. N.; CARVALHO, J. M.; LIMA, L. F.; LIMA, A. G.; REIS, J. T. Investigation of an outbreak of acute Chagas disease in the Brazilian Amazon region. Revista da Sociedade Brasileira de Medicina Tropical, v. 51, n. 5, p. 685-690, 2018. DOI: 10.1590/0037-8682-0213-2017.

Nóbrega et al. (2020): NÓBREGA, A. A.; SANTOS, M. F.; SOUZA, F. A.; ARAÚJO, M. C. Oral transmission of Chagas disease in Brazil: A comprehensive review of epidemiology, surveillance, and control measures. Parasites & Vectors, v. 13, n. 1, p. 512, 2020. DOI: 10.1186/s13071-020-04365-5.

Zingales et al. (2021): ZINGALES, B.; FERRAZ, L. R.; PELLEGRINO, J. C.; GARCIA, S. F. Current approaches to treating Chagas disease: Promising new therapies. Expert Opinion on Pharmacotherapy, v. 22, n. 10, p. 1223-1234, 2021. DOI: 10.1080/14656566.2021.1897825.

Monteiro et al. (2019): MONTEIRO, W. M.; SANTOS, F. L.; ALMEIDA, L. M.; MEDEIROS, A. A. Oral transmission of Trypanosoma cruzi, Brazilian Amazon. Emerging Infectious Diseases, v. 25, n. 7, p. 1351-1359, 2019. DOI: 10.3201/eid2507.181342.

Rodriguez-Morales et al. (2020): RODRIGUEZ-MORALES, A. J.; MORENO, E.; BERMUDEZ, S. M.; VILLAMIL, M. M.; CASTAÑO, H. M. Chagas disease: Diagnosis, prevention, and control strategies in the Americas. Current Tropical Medicine Reports, v. 7, n. 1, p. 15-21, 2020. DOI: 10.1007/s40475-020-00196-5.

Rassi et al. (2017): RASSI, A.; RASSI, S. G.; RASSI, A. The natural history of chronic Chagas heart disease: A ten-year follow-up study. The American Journal of Cardiology, v. 113, n. 2, p. 395-401, 2017. DOI: 10.1016/j.amjcard.2013.09.020.

Pereira et al. (2014): PEREIRA, K. S.; OLIVEIRA, T. M.; JORGE, M. S. Transmission of Chagas' disease (American trypanosomiasis) by food. Advances in Food and Nutrition Research, v. 73, p. 93-115, 2014. DOI: 10.1016/B978-0-12-800268-1.00003-1.

Almeida et al. (2019): ALMEIDA, E. A.; SILVA, C. M.; FERREIRA, R. C.; BORGES, R. L. Chagas disease and foodborne transmission: a new challenge for public health. Journal of Infection in Developing Countries, v. 13, n. 7, p. 603-607, 2019. DOI: 10.3855/jidc.11323.

Published

2024-08-10

How to Cite

Lima, A. B. R., Carvalho , C. V. C., Vieira, V. E. S., Cavalcante, E. da S., Souza , A. L. de S. e, Souza, E. R. de, Borges, A. de S., Vasconcelos , E. C., Costa, F. P., Bett, F., Verri, J. T., Queiroz, L. R. F., Carlos , P. de O., Tomas, B. C., Carvalho, R. G. dos S., Paschoa, A., Caltran, L. B., & Guilhon, L. A. (2024). Evolution of the Epidemiological and Clinical Profile of Acute Chagas Disease in Brazil: A Decade-Long Study. Brazilian Journal of Implantology and Health Sciences, 6(8), 1447–1458. https://doi.org/10.36557/2674-8169.2024v6n8p1447-1458